Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from reta-peptide.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| BPC-157 | 4 | 99.86% | — | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| Retatrutide | SU2505001 | — | 99.03% | LAL | — | View |
| — | — | Janoshik Analytical | — | — | — | View |
| Cagrilintide | 24121601 | — | 99.59% | — | — | View |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| — |
| BPC-157/TB-500 blend | 4 | — | — | — | — | — | — |
| Cagrilintide | 5 | 99.52% | — | — | — | — |
| CJC-1295 with DAC | 3 | 98.60% | — | — | — | — |
| GHK-Cu | 1 | 99.02% | — | — | — | — |
| KLOW (GHK or GHK-Cu/ TB-500/ BPC-157/ KPV) | 2 | — | — | — | — | — | — |
| MOTS-C | 1 | 99.38% | — | — | — | — |
| NAD+ | 4 | — | — | — | — | — | — |
| Retatrutide | 9 | 99.53% | — | — |
| Semaglutide | 5 | 99.64% | — | — | — |
| Sermorelin | 3 | 99.23% | — | — | — | — |
| TB-500 | 2 | 99.62% | — | — | — | — |
| Tesamorelin | 6 | 99.28% | — | — | — | — |
| Tirzepatide | 7 | 99.79% | — | — | — | — |
| Semaglutide |
| DC005A-D230505 |
| — |
| 99.60% |
| MS |
| — |
| View |
| MOTS-C | 20260409 | Janoshik Analytical | 99.38% | — | 2026-04-16 | View |
| CJC-1295 with DAC | 20260409 | Janoshik Analytical | 99.26% | — | 2026-04-16 | View |
| Tesamorelin | 20260409 | Janoshik Analytical | 99.84% | — | 2026-04-16 | View |
| GHK-Cu | 20260409 | Janoshik Analytical | 99.02% | — | 2026-04-16 | View |
| Sermorelin | 20260409 | Janoshik Analytical | 99.66% | — | 2026-04-16 | View |
| TB-500 | 20260409 | Janoshik Analytical | 99.81% | — | 2026-04-16 | View |
| Retatrutide | 20260409 | Janoshik Analytical | 99.53% | — | 2026-04-16 | View |
| BPC-157 | 20260409 | Janoshik Analytical | 99.96% | — | 2026-04-16 | View |
| Tirzepatide | 20260409 | Janoshik Analytical | 99.88% | — | 2026-04-16 | View |
| NAD+ | — | Janoshik Analytical | — | — | 2025-11-21 | View |
| NAD+ | — | Janoshik Analytical | — | — | 2025-11-21 | View |
| KLOW (GHK or GHK-Cu/ TB-500/ BPC-157/ KPV) | — | Janoshik Analytical | — | — | 2025-11-20 | View |
| BPC-157/TB-500 blend | — | Janoshik Analytical | — | — | 2025-11-20 | View |
| KLOW (GHK or GHK-Cu/ TB-500/ BPC-157/ KPV) | — | Janoshik Analytical | — | — | 2025-11-20 | View |
| BPC-157/TB-500 blend | — | Janoshik Analytical | — | — | 2025-11-20 | View |
| Retatrutide | — | Janoshik Analytical | 99.48% | — | 2025-11-19 | View |
| Cagrilintide | — | Janoshik Analytical | 99.34% | — | 2025-11-19 | View |
| Tirzepatide | — | Janoshik Analytical | 99.86% | — | 2025-11-19 | View |
| CJC-1295 DAC | — | Janoshik Analytical | 98.28% | — | 2025-11-19 | View |
| Sermorelin | — | Janoshik Analytical | 99.01% | — | 2025-11-19 | View |
| Tesamorelin | — | Janoshik Analytical | 99.04% | — | 2025-11-19 | View |
| Sermorelin | — | Janoshik Analytical | 99.01% | — | 2025-11-19 | View |
| CJC-1295 DAC | — | Janoshik Analytical | 98.28% | — | 2025-11-19 | View |
| Cagrilintide | — | Janoshik Analytical | 99.34% | — | 2025-11-19 | View |
| Semaglutide | — | Janoshik Analytical | 99.62% | — | 2025-11-19 | View |
| Tesamorelin | — | Janoshik Analytical | 99.04% | — | 2025-11-19 | View |
| Tirzepatide | — | Janoshik Analytical | 99.86% | — | 2025-11-19 | View |
| Semaglutide | — | Janoshik Analytical | 99.62% | — | 2025-11-19 | View |
| Retatrutide | — | Janoshik Analytical | 99.48% | — | 2025-11-19 | View |
| Tirzepatide | — | Janoshik Analytical | 99.78% | — | 2025-07-22 | View |
| Tirzepatide | — | Janoshik Analytical | 99.78% | — | 2025-07-22 | View |
| Retatrutide | — | Janoshik Analytical | 99.66% | — | 2025-07-19 | View |
| Cagrilintide | — | Janoshik Analytical | 99.66% | — | 2025-07-19 | View |
| Tesamorelin | — | Janoshik Analytical | 99.08% | — | 2025-07-19 | View |
| Retatrutide | — | Janoshik Analytical | 99.66% | — | 2025-07-19 | View |
| Tesamorelin | — | Janoshik Analytical | 99.08% | — | 2025-07-19 | View |
| Cagrilintide | — | Janoshik Analytical | 99.66% | — | 2025-07-19 | View |
| BPC-157 | — | Janoshik Analytical | — | — | 2025-07-18 | View |
| NAD+ | — | Janoshik Analytical | — | — | 2025-07-18 | View |
| NAD+ | — | Janoshik Analytical | — | — | 2025-07-18 | View |
| BPC-157 | — | Janoshik Analytical | — | — | 2025-07-18 | View |
| BPC-157 + TB-500 (TB4) Blend | — | Janoshik Analytical | — | — | 2025-07-18 | View |
| BPC-157 + TB-500 (TB4) Blend | — | Janoshik Analytical | — | — | 2025-07-18 | View |
| Retatrutide | RT2503608 | Janoshik Analytical | 99.86% | HM | 2025-04-18 | View |
| Tirzepatide | RT2503608 | Janoshik Analytical | 99.54% | — | 2025-04-18 | View |
| Semaglutide | RT2503608 | Janoshik Analytical | 99.59% | — | 2025-04-18 | View |